ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder

ClinicalTrials.gov ID: NCT02972632

Public ClinicalTrials.gov record NCT02972632. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Single-Arm, Multicenter, Prospective, Phase 4, Interventional, Flexible Dose Study to Evaluate the Effectiveness of Vortioxetine on Goal Achievement After a Change in Antidepressant Medication for the Treatment of Subjects With Major Depressive Disorder

Study identification

NCT ID
NCT02972632
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Takeda
Industry
Enrollment
123 participants

Conditions and interventions

Interventions

  • Vortioxetine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 21, 2016
Primary completion
Feb 5, 2018
Completion
Feb 5, 2018
Last update posted
Jul 10, 2019

2016 – 2018

United States locations

U.S. sites
25
U.S. states
11
U.S. cities
25
Facility City State ZIP Site status
ATP Clinical Research, Inc. Costa Mesa California 92626
ProScience Research Group Culver City California 90230
Behavioral Research Specialists, LLC Glendale California 91206
Pacific Research Partners Oakland California 94607
Excell Research Oceanside California 92056
Anderson Clinical Research Redlands California 92374
University Medical Group Upland California 91207
MCB Clinical Research Centers, LLC Colorado Springs Colorado 80910
Suncoast Clinical Research Inc. New Port Richey Florida 34652
Behavioral Clinical Research , Inc North Miami Florida 33162
Compass Research Main Orlando Florida 32806
University of South Florida Tampa Florida 33613
Great Lakes Clinical Trials Chicago Illinois 60640
Baber Research Group Naperville Illinois 60563
Deaconess Clinic Evansville Indiana 47713-1227
Novex Clinical Research, LLC New Bedford Massachusetts 2740
Coastal Research Associates, Inc. South Weymouth Massachusetts 2190
University of Michigan, Ann Arbor Ann Arbor Michigan 48109
Columbia University Medical Center New York New York 10023
Dayton Clinical Research Dayton Ohio 45406
Green & Seidner Family Practice Associates Lansdale Pennsylvania 19446
Relaro Medical Trials Dallas Texas 75243
Red Oak Psychiatry Associates, PA Houston Texas 77090
Radiant Research, Inc. San Antonio Texas 78229
Family Psychiatry of The Woodlands The Woodlands Texas 77381

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02972632, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2019 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02972632 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →